OncoZenge AB's total assets for Q1 2025 were kr11.74M, an increase of 2.70% from the previous quarter. DE:8LY total liabilities were kr1.75M for the fiscal quarter, a 17.86% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.